Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 955 participants.
Also called NCT02684812
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 955 participants
- Registry
-
NCT02684812
-
- Other papers using this trial's data
- Cost-Effectiveness of Ultra-Early Tranexamic Acid as Add-On to Standard Care After Subarachnoid Hemorrhage (ULTRA Trial)
- Quality of life after tranexamic acid in subarachnoid hemorrhage: post-hoc analysis of the ULTRA trial
- Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial
- Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial
- Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage
- Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT02684812. Randomized; single masking; primary purpose treatment. Start 2012-07-16 (actual); primary completion 2019-07-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.
- Acronym
- ULTRA
- Condition
- Subarachnoid Hemorrhage
- Intervention (Drug)
- Tranexamic Acid
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Collaborator
- Stichting Nuts Ohra
Record details
- Record id
cardio:ct-nct02684812- Content hash
a882bfec62bb5f3a1e79a89359d183e5f71cc902803a175d075e8762c3e14a73